8.67 USD
+0.01 (+0.08%)
AT CLOSE (11:59 AM EDT)
Upstream Bio, Inc. Common Stock (UPB)
NASDAQ: UPB • USD
8.73
+0.06 (+0.66%)
POST MARKET (AS OF 07:57 PM EDT)
Market: CLOSED
Open?$8.72
High?$9.15
Low?$8.10
Prev. Close?$8.67
Volume?939.9K
Avg. Volume?1.6M
VWAP?$8.75
Rel. Volume?0.58x
Bid / Ask
Bid?$8.63 × 100
Ask?$8.66 × 100
Spread?$0.03
Midpoint?$8.65
Valuation & Ratios
Market Cap?471.8M
Shares Out?54.4M
Float?31.1M
Float %?57.5%
P/E Ratio?N/A
P/B Ratio?1.39
EPS?-$2.64
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?26.15Strong
Quick Ratio?26.15Strong
Cash Ratio?7.55Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?1.39CHEAP▾
P/S?165.32HIGH▾
P/FCF?N/A▾
EV/EBITDA?-2.3CHEAP▾
EV/Sales?129.73HIGH▾
Returns & Efficiency
ROE?-42.2%WEAK▾
ROA?-40.6%WEAK▾
Cash Flow & Enterprise
FCF?$-133440000
Enterprise Value?$370.2M
Related Companies
Loading...
News
Profile
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
Employees
75
Market Cap
471.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-11
Address
890 WINTER STREET, SUITE 200
WALTHAM, MA 02451
Phone: 781-208-2466
WALTHAM, MA 02451
Phone: 781-208-2466